Peptide Technologies Inc (PEPT) financial statements (2021 and earlier)
Company profile
| Business Address |
5348 VEGAS DRIVE #177 LAS VEGAS, NV 89108 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| SIC | 2844 - Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2020 TTM | 3/31/2020 | 3/31/2019 | 3/31/2018 | 11/30/2014 | 11/30/2013 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 2 | 5 | 89 | 2 | 1 | 0 | ||
| Cash and cash equivalents | 2 | 5 | 89 | 2 | 1 | 0 | ||
| Inventory, net of allowances, customer advances and progress billings | 248 | 247 | ✕ | |||||
| Inventory | 248 | 247 | ||||||
| Prepaid expense | 9 | |||||||
| Other undisclosed current assets | 51 | |||||||
| Total current assets: | 250 | 252 | 98 | 2 | 1 | 51 | ||
| Noncurrent Assets | ||||||||
| Intangible assets, net (including goodwill) | 3 | 7 | 8 | 13 | 3 | ✕ | ||
| Intangible assets, net (excluding goodwill) | 3 | 7 | 8 | 13 | 3 | |||
| Other noncurrent assets | 3 | |||||||
| Other undisclosed noncurrent assets | (51) | |||||||
| Total noncurrent assets: | 3 | 7 | 8 | 13 | 5 | (51) | ||
| Other undisclosed assets | (3) | |||||||
| TOTAL ASSETS: | 253 | 259 | 106 | 15 | 4 | 0 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 344 | 318 | 274 | 269 | 689 | |||
| Accounts payable | 59 | 51 | 38 | 38 | 37 | |||
| Accrued liabilities | 65 | 45 | 15 | 10 | 42 | |||
| Employee-related liabilities | 221 | 221 | 221 | 221 | 580 | |||
| Other undisclosed accounts payable and accrued liabilities | 30 | |||||||
| Debt | 209 | 70 | ||||||
| Due to related parties | 131 | 131 | 131 | 67 | ||||
| Total current liabilities: | 685 | 519 | 405 | 336 | 689 | |||
| Noncurrent Liabilities | ||||||||
| Other undisclosed noncurrent liabilities | 118 | 222 | 70 | |||||
| Total noncurrent liabilities: | 118 | 222 | 70 | |||||
| Other undisclosed liabilities | 110 | 1,751 | ||||||
| Total liabilities: | 803 | 740 | 475 | 336 | 799 | 1,751 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (551) | (481) | (370) | (321) | (795) | (1,700) | ||
| Common stock | 127 | 127 | 127 | 127 | 156 | |||
| Additional paid in capital | 777 | 777 | 777 | 732 | 188 | 148 | ||
| Accumulated deficit | (1,455) | (1,385) | (1,274) | (1,180) | (106) | (106) | ||
| Other undisclosed stockholders' equity attributable to parent | (1,034) | (1,743) | ||||||
| Total stockholders' equity: | (551) | (481) | (370) | (321) | (795) | (1,700) | ||
| TOTAL LIABILITIES AND EQUITY: | 253 | 259 | 106 | 15 | 4 | 51 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2020 TTM | 3/31/2020 | 3/31/2019 | 3/31/2018 | 11/30/2014 | 11/30/2013 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 1 | 3 | 0 | ||||
| Financial services revenue | ✕ | ✕ | ✕ | 0 | |||
| Cost of revenue | (2) | (2) | |||||
| Gross profit: | (1) | 1 | 0 | ||||
| Operating expenses | (57) | (78) | 92 | (49) | (25) | (34) | |
| Other undisclosed operating loss | (183) | ||||||
| Operating loss: | (58) | (77) | (92) | (49) | (25) | (34) | |
| Nonoperating income (expense) | (70) | (35) | (1) | (0) | 6 | ||
| Foreign currency transaction gain (loss), before tax | (2) | (6) | (1) | (0) | 6 | ||
| Interest and debt expense | (78) | (29) | 1 | (4) | 4 | ||
| Loss from continuing operations before equity method investments, income taxes: | (205) | (140) | (92) | (50) | (22) | (29) | |
| Other undisclosed loss from continuing operations before income taxes | (445) | ||||||
| Loss before gain (loss) on sale of properties: | (205) | (140) | (92) | (50) | (468) | (29) | |
| Other undisclosed net income | 196 | 252 | 186 | 99 | 1,328 | ||
| Net income (loss): | (9) | 112 | 94 | 50 | 860 | (29) | |
| Other undisclosed net loss attributable to parent | (100) | (223) | (187) | (99) | |||
| Net income (loss) available to common stockholders, diluted: | (110) | (112) | (94) | (50) | 860 | (29) | |
Comprehensive Income ($ in thousands)
| 12/31/2020 TTM | 3/31/2020 | 3/31/2019 | 3/31/2018 | 11/30/2014 | 11/30/2013 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (9) | 112 | 94 | 50 | 860 | (29) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (9) | 112 | 94 | 50 | 860 | (29) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.